Search Legislation

The Health Services (Cross-Border Health Care) (Amendment) Regulations (Northern Ireland) 2015

What Version

 Help about what version
  • Latest available (Revised)
  • Original (As made)

Opening Options

 Help about opening options

Status:

This is the original version (as it was originally made). This item of legislation is currently only available in its original format.

Citation and commencement

1.  These Regulations may be cited as The Health Services (Cross-Border Health Care) (Amendment) Regulations (Northern Ireland) 2015 and shall come into operation on 27th March 2015.

Amendments to the Health Services (Cross-Border Health Care) Regulations (Northern Ireland) 2013

2.—(1) The Health Services (Cross-Border Health Care) Regulations (Northern Ireland) 2013(1) are amended as follows.

(2) After regulation 5 (National Contact Point: Information about treatment in another member State) insert—

National Contact Point: information about prescriptions intended to be used in another member State

5A.(1) The NCP must make available to patients information about the elements, specified in the Schedule, to be included in a prescription which is—

(a)issued in one member State, and

(b)intended to be used in another member State..

(3) Add the following Schedule—

Regulation 5A

SCHEDULEElements that must be included in prescriptions intended to be used in another member State

1.  The patient’s—

(a)surname,

(b)first names, and

(c)date of birth.

2.  The issue date of the prescription.

3.  The prescribing professional’s—

(a)surname,

(b)first names,

(c)professional qualification,

(d)direct contact details including—

(i)email address, and

(ii)telephone or fax number with the appropriate international prefix,

(e)work address,

(f)member State in which the professional works,

(g)signature (either written in ink or electronic depending on the medium chosen for issuing the prescription).

4.  The details of the prescribed product, including where applicable the—

(a)common name as defined by Article 1 of Directive 2001/83/EC of the European Parliament and of the Council of 6 November 2001 on the Community code relating to medicinal products for human use (“Directive 2001/83/EC”)(2),

(b)brand name if—

(i)the prescribed product is a biological medicinal product, as defined in point 3.2.1.1(b) of Annex 1 (Part 1) to Directive 2001/83/EC, or

(ii)the prescribing professional deems it medically necessary for that product to be dispensed and, in that case, the prescribing professional’s reasons justifying the use of the brand name,

(c)pharmaceutical formulation (such as tablet, solution etc),

(d)quantity,

(e)strength, as defined in Article 1 of Directive 2001/83/EC, and

(f)dosage regimen..

Sealed with the Official Seal of the Department of Health, Social Services and Public Safety on 6th March 2015

(L.S.)

Mark Lee

A senior officer of the Department of Health, Social Services and Public Safety

Back to top

Options/Help

Print Options

Close

Legislation is available in different versions:

Latest Available (revised):The latest available updated version of the legislation incorporating changes made by subsequent legislation and applied by our editorial team. Changes we have not yet applied to the text, can be found in the ‘Changes to Legislation’ area.

Original (As Enacted or Made):The original version of the legislation as it stood when it was enacted or made. No changes have been applied to the text.

Close

Opening Options

Different options to open legislation in order to view more content on screen at once

Close

Explanatory Memorandum

Explanatory Memorandum sets out a brief statement of the purpose of a Statutory Rule and provides information about its policy objective and policy implications. They aim to make the Statutory Rule accessible to readers who are not legally qualified and accompany any Northern Ireland Statutory Rule or Draft Northern Ireland Statutory Rule laid before the UK Parliament during the suspension of the Northern Ireland Assembly.

Close

More Resources

Access essential accompanying documents and information for this legislation item from this tab. Dependent on the legislation item being viewed this may include:

  • the original print PDF of the as enacted version that was used for the print copy
  • lists of changes made by and/or affecting this legislation item
  • confers power and blanket amendment details
  • all formats of all associated documents
  • correction slips
  • links to related legislation and further information resources
Close

More Resources

Use this menu to access essential accompanying documents and information for this legislation item. Dependent on the legislation item being viewed this may include:

  • the original print PDF of the as made version that was used for the print copy
  • correction slips

Click 'View More' or select 'More Resources' tab for additional information including:

  • lists of changes made by and/or affecting this legislation item
  • confers power and blanket amendment details
  • all formats of all associated documents
  • links to related legislation and further information resources